Decreased NURR1 gene expression in patients with Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Neurological Sciences

• Publication date

  2008-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jns.2008.06.007PMID 18684475PMCID PMC2572302
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transcriptional regulation of mesencephalic dopaminergic neurons: The full circle of life and death

  2008cited by this paper
• A Nurr1 point mutant, implicated in Parkinson's disease, uncouples ERK1/2-dependent regulation of tyrosine hydroxylase transcription.

  2008cited by this paper
• Metabolomic profiling to develop blood biomarkers for Parkinson's disease.

  2008cited by this paper
• Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.

  2008cited by this paper
• Molecular markers of early Parkinson's disease based on gene expression in blood

  2007cited by this paper
• Low plasma uric acid level in Parkinson's disease

  2007cited by this paper
• Plasma urate and risk of Parkinson's disease.

  2007cited by this paper
• Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease.

  2006cited by this paper
• Translated mutation in the Nurr1 gene as a cause for Parkinson's disease

  2006cited by this paper
• Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease.

  2006cited by this paper
• Nurr1 in Parkinson's disease and related disorders

  2006cited by this paper
• Age-dependent dopaminergic dysfunction in Nurr1 knockout mice.

  2005cited by this paper
• The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease.

  2005cited by this paper
• Progression of Parkinson disease: are we making progress in charting the course?

  2005cited by this paper
• Serum uric acid levels and the risk of Parkinson disease

  2005cited by this paper
• Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations

  2004cited by this paper
• Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry

  2003cited by this paper
• A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease.

  2003cited by this paper
• Mutations in NR4A2 associated with familial Parkinson disease

  2003cited by this paper
• Diagnostic criteria for Parkinson's disease

  2003cited by this paper
• Peripheral Markers of Apoptosis in Parkinson's Disease

  2003cited by this paper
• Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease.

  2003cited by this paper
• Erratum: Mutations in NR4A2 associated with familial Parkinson disease (Nature Genetics (2003) 33 (85-89))

  2003cited by this paper
• Age‐related decreases in Nurr1 immunoreactivity in the human substantia nigra

  2002cited by this paper
• Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson’s disease

  2002cited by this paper
• Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease

  2001cited by this paper
• Diagnostic criteria for Parkinson disease.

  1999cited by this paper
• Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice.

  1999cited by this paper
• Reduced Nurrl Expression Increases the Vulnerability of Mesencephalic Dopamine Neurons to MPTP‐Induced Injury

  1999cited by this paper
• Increased expression of dopamine receptors on lymphocytes in Parkinson's disease

  1999cited by this paper
• Reduced dopamine in peripheral blood lymphocytes in Parkinson's disease.

  1999cited by this paper
• (R) salsolinol N‐methyltransferase activity increases in parkinsonian lymphocytes

  1998cited by this paper
• Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons.

  1998cited by this paper
• Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene.

  1998cited by this paper
• Dopamine neuron agenesis in Nurr1-deficient mice.

  1997cited by this paper
• Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease

  1996cited by this paper
• NOT, a human immediate-early response gene closely related to the steroid/thyroid hormone receptor NAK1/TR3.

  1994cited by this paper
• Identification of a new brain-specific transcription factor, NURR1.

  1992cited by this paper

• De novo identification of potent ingredients for proteasome activation in MT101-5 using an AI-driven approach.

  2026cites this paper
• Unravelling the Role of Tyrosine and Tyrosine Hydroxylase in Parkinson's Disease: Exploring Nanoparticle-based Gene Therapies.

  2025cites this paper
• Nurr1 deficiency impairs autophagy-lysosomal function through GBA-dependent transcriptional regulation in Parkinson’s disease pathogenesis

  2025cites this paper
• Regulation of NR4A2 Gene Expression and Its Importance in Neurodegenerative and Psychiatric Diseases

  2025cites this paper
• The multiple mechanisms of NR4A2 in neurological disorders and advances in targeted therapy research.

  2025cites this paper
• Gene Therapy for Parkinson’s Disease Using Midbrain Developmental Genes to Regulate Dopaminergic Neuronal Maintenance

  2024cites this paper
• Increased levels of regulatory T cells and IL-10-producing regulatory B cells are linked to improved clinical outcome in Parkinson’s disease: a 1-year observational study

  2024cites this paper
• Synaptogyrin-3 Prevents Cocaine Addiction and Dopamine Deficits

  2024cites this paper
• Multiomics approach discloses lipids and metabolites profiles associated to Parkinson's disease stages and applied therapies.

  2024cites this paper
• Metabolomic modelling and neuroprotective effects of carvacrol against acrylamide toxicity in rat's brain and sciatic nerve

  2024cites this paper
• International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023

  2023cites this paper
• Single-nuclei RNA sequencing uncovers heterogenous transcriptional signatures in Parkinson’s disease associated with nuclear receptor-related factor 1 defect

  2023cites this paper
• Coordinated modification in expression levels of HSPA1A/B, DGKH, and NOTCH2 in Parkinson’s patients’ blood and substantia nigra as a diagnostic sign: the transcriptomes’ relationship

  2023cites this paper
• The Crucial Roles of Pitx3 in Midbrain Dopaminergic Neuron Development and Parkinson’s Disease-Associated Neurodegeneration

  2023cites this paper
• GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson’s Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson’s Disease-Relevant Pathogenic Mechanisms

  2023cites this paper
• lncRNA Sequencing Reveals Neurodegeneration-associated FUS Mutations Alter Transcriptional Landscape of iPS Cells That Persists In Motor Neurons

  2023cites this paper
• Anti-inflammatory effects of myristic acid mediated by the NF-κB pathway in lipopolysaccharide-induced BV-2 microglial cells.

  2023cites this paper
• An optimized Nurr1 agonist provides disease-modifying effects in Parkinson’s disease models

  2023cites this paper
• lncRNA Sequencing Reveals Neurodegeneration-Associated FUS Mutations Alter Transcriptional Landscape of iPS Cells That Persists in Motor Neurons

  2023cites this paper
• Unilateral rNurr1-V5 transgene expression in nigral dopaminergic neurons mitigates bilateral neuropathology and behavioral deficits in parkinsonian rats with α-synucleinopathy

  2023cites this paper
• The role of Nurr1-miR-30e-5p-NLRP3 axis in inflammation-mediated neurodegeneration: insights from mouse models and patients’ studies in Parkinson’s disease

  2023cites this paper
• Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson’s Disease

  2022cites this paper
• Neuroprotective effects of a lead compound from coral via modulation of the orphan nuclear receptor Nurr1

  2022cites this paper
• Embelin and levodopa combination therapy for improved Parkinson’s disease treatment

  2022cites this paper
• The role of NURR1 in metabolic abnormalities of Parkinson’s disease

  2022cites this paper
• Mitochondrial Function and Dynamics in Neural Stem Cells and Neurogenesis: Implications for Neurodegenerative Diseases.

  2022cites this paper
• Transcriptional Regulation of the Synaptic Vesicle Protein Synaptogyrin-3 (SYNGR3) Gene: The Effects of NURR1 on Its Expression

  2022cites this paper
• Genome-Wide DNA Methylation in Policemen Working in Cities Differing by Major Sources of Air Pollution

  2022cites this paper
• NURR1‐deficient mice have age‐ and sex‐specific behavioral phenotypes

  2022cites this paper
• Parkinsonism

  2021cites this paper
• Nr4a2 Transcription Factor in Hippocampal Synaptic Plasticity, Memory and Cognitive Dysfunction: A Perspective Review

  2021cites this paper
• The emerging role of miRNA-132/212 cluster in neurologic and cardiovascular diseases: Neuroprotective role in cells with prolonged longevity.

  2021cites this paper
• Analogs of the Dopamine Metabolite 5,6-Dihydroxyindole Bind Directly to and Activate the Nuclear Receptor Nurr1 (NR4A2)

  2021cites this paper
• Recent Progress in Non-motor Features of Parkinson’s Disease with a Focus on Circadian Rhythm Dysregulation

  2021cites this paper
• Nurr1 deficiency shortens free running period, enhances photoentrainment to phase advance, and disrupts circadian cycling of the dopamine neuron phenotype.

  2021cites this paper
• Failure of Glial Cell-Line Derived Neurotrophic Factor (GDNF) in Clinical Trials Orchestrated By Reduced NR4A2 (NURR1) Transcription Factor in Parkinson’s Disease. A Systematic Review

  2021cites this paper
• Comprehensive metabolic profiling of Parkinson’s disease by liquid chromatography-mass spectrometry

  2021cites this paper
• Down regulation of DNA topoisomerase IIβ exerts neurodegeneration like effect through Rho GTPases in cellular model of Parkinson’s disease by Down regulating tyrosine hydroxylase

  2021cites this paper
• Associations of ATG7 rs1375206 polymorphism and elevated plasma ATG7 levels with late-onset sporadic Parkinson’s disease in a cohort of Han Chinese from southern China

  2020cites this paper
• Pathophysiological, toxicological, and immunoregulatory roles of reactive oxygen and nitrogen species (RONS)

  2020cites this paper
• The transcription factor Nurr1 is upregulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice

  2020cites this paper
• Possible therapies of Parkinson's disease: A review.

  2020cites this paper
• Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications

  2020cites this paper
• Working memory deficits in schizophrenia are associated with the rs34884856 variant and expression levels of the NR4A2 gene in a sample Mexican population: a case control study

  2020cites this paper
• The transcription factor Nurr1 is up-regulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice.

  2020cites this paper
• Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside

  2020cites this paper
• A review of possible therapies for Parkinson's disease.

  2020cites this paper
• Nurr1Cd11bcre conditional knockout mice display inflammatory injury to nigrostriatal dopaminergic neurons.

  2020cites this paper
• Working Memory De cits in Schizophrenia Are Associated With the Rs34884856 Variant and Expression Levels of the NR4A2 Gene in a Sample Mexican Population: A Case Control Study

  2020cites this paper
• Wnt 1 silencing enhances neurotoxicity induced by paraquat and maneb in SH ‐ SY 5 Y cells

  2019cites this paper
• Wnt1 silencing enhances neurotoxicity induced by paraquat and maneb in SH-SY5Y cells.

  2019cites this paper
• Transcriptomic Characterization of the Human Insular Cortex and Claustrum

  2019cites this paper
• Repeated bifenthrin exposure alters hippocampal Nurr-1/AChE and induces depression-like behavior in adult rats.

  2019cites this paper
• Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease

  2019cites this paper
• Molecular Insights into NR4A2(Nurr1): an Emerging Target for Neuroprotective Therapy Against Neuroinflammation and Neuronal Cell Death

  2019cites this paper
• Altered Expression Levels of MicroRNA-132 and Nurr1 in Peripheral Blood of Parkinson's Disease: Potential Disease Biomarkers.

  2019cites this paper
• Effect of methamphetamine on rat primary midbrain cells; mitochondrial biogenesis as a compensatory response.

  2019cites this paper
• Activation of Peroxisome Proliferator-Activated Receptor-α Increases the Expression of Nuclear Receptor Related 1 Protein (Nurr1) in Dopaminergic Neurons

  2019cites this paper
• Cicadidae Periostracum, the Cast-Off Skin of Cicada, Protects Dopaminergic Neurons in a Model of Parkinson's Disease

  2019cites this paper
• Pyrethroid exposure and neurotoxicity: a mechanistic approach

  2019cites this paper
• Covalent Modification and Regulation of the Nuclear Receptor Nurr1 by a Dopamine Metabolite

  2018cites this paper
• An Improved Prevention and Treatment of Parkinson’s Disease - A Review Considering Recent Findings in Genetics with Helpful Treatments

  2018cites this paper
• Alterations of NURR1 and Cytokines in the Peripheral Blood Mononuclear Cells: Combined Biomarkers for Parkinson’s Disease

  2018cites this paper
• Gene Therapy for Parkinson’s Disease, An Update

  2018cites this paper
• Protective effects of a herbal extract combination of Bupleurum falcatum, Paeonia suffruticosa, and Angelica dahurica against MPTP-induced neurotoxicity via regulation of nuclear receptor-related 1 protein.

  2017cites this paper
• Neuroinflammation as a Potential Mechanism Underlying Parkinsons Disease

  2017cites this paper
• Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic, & circadian dysfunction in Parkinson's disease. An integrated strategy for management.

  2017cites this paper
• Transcription Factors: Potential Cell Death Markers in Parkinson’s Disease

  2017influential citation
• Can Biomarkers Help the Early Diagnosis of Parkinson’s Disease?

  2017cites this paper
• NUCLEAR RECEPTORS AS THERAPEUTIC TARGETS FOR ALZHEIMER’S DISEASE

  2017cites this paper
• A20 in Multiple Sclerosis and Parkinson’s Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways?

  2017cites this paper
• Identification of NURR1 (Exon 4) and FOXA1 (Exon 3) Haplotypes Associated with mRNA Expression Levels in Peripheral Blood Lymphocytes of Parkinson's Patients in Small Indian Population

  2017cites this paper
• NR4A2 genetic variation and Parkinson's disease: Evidence from a systematic review and meta-analysis.

  2017cites this paper
• In vivo and in silico studies to identify mechanisms associated with Nurr1 modulation following early life exposure to permethrin in rats.

  2017cites this paper
• Association of polymorphisms and reduced expression levels of the NR4A2 gene with Parkinson's disease in a Mexican population.

  2017cites this paper
• Modulatory Role of Nurr1 Activation and Thrombin Inhibition in the Neuroprotective Effects of Dabigatran Etexilate in Rotenone-Induced Parkinson’s Disease in Rats

  2017cites this paper
• Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor-Nuclear Receptor Related 1 Protein Dimer Activation.

  2016cites this paper
• Efficient and biologically relevant consensus strategy for Parkinson’s disease gene prioritization

  2016cites this paper
• Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson’s and Alzheimer’s Disease Patients

  2016influential citation
• Nurr1‐Based Therapies for Parkinson's Disease

  2016cites this paper
• Integrated analysis of DNA methylation and RNA‑sequencing data in Down syndrome.

  2016cites this paper
• Nuclear receptor 4A (NR4A) family - orphans no more.

  2016cites this paper
• Simultaneous imaging and relative quantitation of multiple neurotransmitters in a progressive Parkinson ’ s disease model by MALDI mass spectrometry

  2016influential citation
• ge-related gene expression changes in substantia nigra dopamine eurons of the rat

  2015cites this paper
• Diagnosis of Parkinson’s disease: progress and future prospects

  2015cites this paper
• Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease

  2015cites this paper
• Dopamine Agonists Exert Nurr1-inducing Effect in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease

  2015cites this paper
• Neuroprotective potential of AAV-mediated NURR1 expression in a rat model of Parkinson’s disease

  2015cites this paper
• A High-Efficiency Induction of Dopaminergic Cells from Human Umbilical Mesenchymal Stem Cells for the Treatment of Hemiparkinsonian Rats

  2015cites this paper
• Novel para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and suppress glial activation in a mouse model of Parkinson's disease.

  2015cites this paper
• Three-dimensional (3D) culture of bone-derived human 786-O renal cell carcinoma retains relevant clinical characteristics of bone metastases.

  2015cites this paper
• Translational Strategies to address Parkinson's disease

  2015cites this paper
• Nurr1: A New Insight to Protects Dopaminergic Neurodegeneration in Parkinson’s disease

  2014cites this paper
• The lifelong maintenance of mesencephalic dopaminergic neurons by Nurr1 and engrailed

  2014cites this paper
• Effects of Isoxazolo-Pyridinone 7e, a Potent Activator of the Nurr1 Signaling Pathway, on Experimental Autoimmune Encephalomyelitis in Mice

  2014cites this paper
• Nurr1: a new lnsight to protects dopaminergic neurodegeneration in parkinson’s disease

  2014cites this paper
• Prepulse Inhibition is Associated with Attention, Processing Speed, and 123I-FP-CIT SPECT in Parkinson's Disease

  2014cites this paper
• Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease.

  2014cites this paper
• Induction of Neurotrophic and Differentiation Factors in Neural Stem Cells by Valproic Acid

  2014cites this paper
• Parkinson’s Disease and the “sunshine” vitamin

  2013cites this paper